CAS: 12584-58-6; Insulin

该化合物是一种高纯度的浮游胰岛素制剂,主要用作分析和生物分析应用的参考标准,其特征明确的结构和生物活动使染色体系统,特别是HPLC和UPLC对胰岛素的分析方法具有理想性.该产品确保了一致的留存时间,峰值对称和分辨率,有助于方法开发和系统性能核查.它与药理标准(如USP,EP)的兼容性提高了质量控制工作流程的可靠性.该制剂经过严格测试,以识别性,能和纯度,在制药测试环境中提供可追踪性和可复制性.对于研究和受监管的实验室来说是合适的.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7888116-B2
    优先权日:2004-07-22
    标 题 :Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases
    发明人:EGAN JOSEPHINE M; DOYLE MAIRE E
    权利人:US HEALTH
    摘要:Disclosed are methods for identifying and isolating a precursor cell. Also, disclosed are methods of increasing insulin synthesis from a pancreatic B-cell. Further, disclosed are methods of improving pancreatic B-cell function. Still further, disclosed are methods of preventing or delaying the onset of a metabolic disease, methods of treating or preventing a metabolic disease in a subject, and to compositions for treating or preventing a metabolic disease in a subject in need of such treatment or prevention.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Gekkan Yakuji. Pharmaceuticals Monthly., 22(1313), 1980
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知